DEFENCATH (TAUROLIDINE/HEPARIN)

Serial Number 90766720
606

Registration Progress

Application Filed
Jun 10, 2021
Under Examination
Jun 21, 2022
Approved for Publication
Apr 26, 2022
Published for Opposition
Apr 26, 2022
Registered

Trademark Image

DEFENCATH (TAUROLIDINE/HEPARIN)

Basic Information

Serial Number
90766720
Filing Date
June 10, 2021
Published for Opposition
April 26, 2022
Abandonment Date
July 22, 2024
Drawing Code
5

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 22, 2024
Classes
005

Rights Holder

CorMedix Inc.

03
Address
300 Connell Drive, Suite 4200
Berkeley Heights, NJ 07922

Ownership History

CorMedix Inc.

Original Applicant
03
Berkeley Heights, NJ

CorMedix Inc.

Owner at Publication
03
Berkeley Heights, NJ

Legal Representation

Attorney
Margaret M. Carley

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

34 events
Date Code Type Description Documents
Jul 22, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 22, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 18, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 18, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 17, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 15, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 15, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 15, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 12, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 20, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 16, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 16, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 16, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 21, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 26, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 26, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 6, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 23, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 23, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 23, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 23, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 23, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 17, 2022 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Mar 15, 2022 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Mar 2, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 2, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 2, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 2, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 2, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 1, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 31, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 14, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Antimicrobial solution containing both taurolidine and heparin for use as a catheter lock solution

Additional Information

Design Mark
The mark consists of the stylized words "DEFENCATH (TAUROLIDINE/HEPARIN)" with the words "(TAUROLIDINE/HEPARIN)" positioned below the word "DEFENCATH."

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"(TAUROLIDINE/HEPARIN)"